Spyre Therapeutics, Inc. (NASDAQ:SYRE) has 151 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,539,357 | 38.65% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 2,578,675 | 28.46% | $0.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -91,273 | -33.34% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 550,000 | 15.18% | $0.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 0 | 1,000,000 | 37.24% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 697 | 173.82% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 984,344 | 32.27% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | 400,161 | 20.13% | $0.00 |
| Capital International Investors | 31 Dec, 2025 | 0 | 1,100,000 | 45.98% | $0.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 0 | 800,000 | 72.69% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | 1,839,780 | 149.64% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | -943,789 | -36.60% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 822,045 | 39.90% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 477,633 | 26.76% | $0.00 |
| Remedium Capital Partners, LLC | 31 Dec, 2025 | 0 | 1,456,231 | 0.00% | $0.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -1,307,800 | -40.87% | $0.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 0 | 13,292 | 0.94% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 1,816,009 | 13,969.30% | $0.00 |